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Abstract
Background: Since the first isolation of the Rift Valley Fever virus (RVFV) in 1930s, there have been several epizootics 
outbreaks in the tropic mainly in Africa including Sudan. Recognition of cases and diagnosis of RVF are critical for 
management and control of the disease.
Aims: To investigate the seroprevalence and risk factors for seropostive to RVFV IgG among febrile patients.
Methods: All febrile patients presented to New Halfa hospital in eastern Sudan during September through November 
2007 were investigated to identify the cause of their fever including malaria and RFV.
Results: Out of 290 feverish patients presented to the hospital, malaria was diagnosis in 94 individuals. Fevers of 
unknown origin were diagnosed in 149 patients. Seropostive to RVFV IgG was detected by enzyme-linked 
immunosorbent assay in 122 (81.8%) of the sera from these 149 patients with fever of unknown origin. While socio-
demographic characteristics (age, Job, education and residency) were not associated with seropostive to RVFV IgG, 
male (OR = 2.8, 95% CI = 1.0-7.6; P = 0.04) were at three times higher risk for seropostive to RVFV IgG.
Conclusion: There was a high seropostive to RVFV IgG in this setting, more research is needed perhaps using other 
methods like PCR and IGM.
Introduction
The Rift Valley Fever virus (RVFV) of the family Bunya-
viridae is a cause of zoonotic viral disease [1]. Since the
first isolation of the virus in1930s, there have been several
epizootics outbreaks in tropic mainly in Africa including
Sudan, which is the largest country in Africa [2,3]. RVFV
Infection in humans can be acquired through mosquito
bites, through contact with infected animals and vertical
transmission has been reported [4]. RVF can present as
uncomplicated acute febrile illness, however severe com-
plications, such as hemorrhagic disease, meningoenceph-
alitis, renal failure and blindness have been reported
[2,5,6]. Generally, it has been estimated that only approx-
imately 1%-2% of infections result in fatal hemorrhagic
fever [7]. It has been reported that significant high-preva-
lence clusters of RVF encompassed areas that had experi-
enced previous epidemics of RVF [8].
RVF and other arthropod-borne pathogens as the cause
of an outbreak of febrile illnesses were reported previ-
ously, following previous flooding in the different regions
of Sudan [9-11]. Furthermore, recently RVF causing out-
break in has been reported in Sudan [2,3]. The impor-
tance of recognition of cases and diagnosis, especially in
malaria endemic areas, of these viruses are critical for
management and control of the disease. Hence, effective
countrywide surveillance backed by diagnosis is highly
recommended. Due to the on-going climatic changes,
such epidemic-outbreaks are expected to occur following
the rainy season. According to our experience in New
Halfa area, febrile illness and malaria are the major health
problems [12,13]. It is worth mentioning that not all of
these are malaria cases, hence it would be of paramount
importance to conduct surveys for RVF [12,13]. Strength-
ened surveillance, early detection, management of cases
seemed to be among the best options to prevent exten-
sion of RVF epidemic foci. Precise estimation of specific
weight for each risk factor is a considerable guide to con-
struct an effective outbreak control plan. Thus the objec-
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tive of the present study was to investigate the prevalence
and risk factor -if any- for RVF among febrile patients
presented at New Halfa Hospital in eastern Sudan.
Methods
The study was conducted in New Halfa hospital in east-
ern Sudan during October through December 2007 to
investigate the seroprevalence and risk factors for RVFV
among febrile patients. The hospital served around
500000 populations in New Hlafa, eastern Sudan. This
area is located at 500 km from Khartoum in the middle of
the second largest irrigated agricultural scheme in Sudan.
Cotton and wheat are the main crops cultivated during
the winter season. The region is semi arid dry of Savan-
nah belt of Sudan characterized by mean temperature of
29.4°C (range 14.1-42.7°C). After signing an informed
consent, detailed medical history was gathered by the
physician from all febrile patients (temperature ≥ 37.5°C)
using questionnaires. Then medical history and physical
examinations including the vital sings were followed by
suitable optimum investigations e.g. chest x-ray, urine
analyses, urine culture and sensitivity, Widal test for
typhoid, paratyphoid and brucellosis and blood film for
malaria.
A suspected human RVF case-patient was defined as a
person with fever associated or not with hemorrhagic
jaundice, and neurological symptoms. A confirmed
human RVFV case-patient was defined as immunoglobu-
lin G (IgG). For each case, blood samples were collected
and an interview in which information was gathered
about sex, age, date of fever onset, profession and hemor-
rhagic symptoms-if any- for all patients.
Ethics
The study received ethical clearance from the Research
Board at the Faculty of Medicine, University of Khar-
toum, Sudan.
Statistics
The data were entered in computer using SPSS for win-
dow (version 13.0) and double checked before analyses.
Frequencies were calculated. Logistic regression analyses
were performed using the seropostive to RVFV IgG as
dependent variable and the socio-demographic charac-
teristics as independent variables. Odd ratios and 95%
confidence interval were calculated and P < 0.05 was con-
sidered significant.
Results
Out of 290 patients with fever presented to the hospital,
diagnosis of malaria, based primarily on clinical presenta-
tion was made in 94 individuals. Thirty two and 24
patients had respiratory and urinary tract infections,
respectively. Fevers of unknown origin were diagnosed in
149 patients and some patients had mixed infections.
Seropostive to RVFV IgG was detected by enzyme-linked
immunosorbent assay in 122 (81.8%) of the sera from
these 149 patients with fever of unknown origin.
Different symptoms were observed among these 149
patients e.g. fever, sweating, headache, chills. None of the
patients presented with hemorrhagic symptoms and
there was no death. Out of these149 patients, 107 (71.8%)
were male, 60(40.3%) were illiterate, 80(53.7%) were rural
residence. The mean (SD) of these 149 patients was
36.6(13.8) years and the mean (SD) of their illness was 6.1
(4.5) days.
Factors associated with seropostive to RVFV IgG
While socio-demographic characteristics (age, Job, edu-
cation and residency) were not associated with seropos-
tive to RVFV IgG, male (OR = 2.8, 95% CI = 1.0-7.6; P =
0.04 were at three times higher risk for seropostive to
RVFV IgG, table 1.
Discussion
The main findings of the current study were; the high
prevalence of seropostive to RVFV IgG in the area and
male were at three times higher risk for RVF. RVF out-
breaks usually occur during the seasons of high rainfall
when the mosquito population is abundant. The periods
between the outbreaks may extend to several decades
during which it is difficult to diagnose cases of RVFV
infection except with special epidemiologic and labora-
tory techniques. Antibodies to RVFV infection can be
diagnosed by detection of IgG antibodies to RVFV in the
serum. Thus, suspect cases can be observed through
active surveillance and diagnosis can be confirmed by
Table 1: Showing logistic regression analysis for seropostive to RVFV IgG in New Halfa hospital, eastern Sudan.
The variables OR 95% CI P
Age 1.0 0.9-1.0 0.2
Gender, male 2.8 1.0-7.6 0.04
Job 1.9 0.7-5.6 0.19
Residency 1.9 0.7-5.4 0.1
Education 2.1 0.7-5.9 0.1Hassanain et al. Virology Journal 2010, 7:97
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detection of IgM antibodies. Although virus isolation is
considered as gold standard method, IgM-ELISA method
avoids false positive results due to the presence of rheu-
matoid factor and antinuclear antibodies. On the other
hand, anti-RVFV antibodies were estimated to persist at a
detectable level for long time in chronic infections [14].
Thus, combination of ELISA and PCR assays is very
important for rapid and efficient identification of RVFV
during outbreaks. The data obtained during the epidem-
ics of RVF in neighboring in Kenya [15], as well as in
Saudi Arabia and Yemen [16] demonstrated the impor-
tance of combining diagnostic assays for accurate and
comprehensive detection of RVFV infection.
In the current study there were various symptoms and
there were no hemorrhagic manifestations among these
patients. Recently we observed various severe manifesta-
tions of RVF in the central Sudan [2] and Seufi and Galal
observed RVFV in the different region of Sudan among
the mosquitoes and human being as well [17].
In the current study age and job were not predictors for
seropostive to RVFV IgG. However, males were observed
to have higher risk for severe RVF in central Sudan [2] as
well as in this study. Previous results from different
region of Sudan indicated that males of 15-29 years old
were more susceptible to RVF than females. In parallel,
housewives and farmers were the most susceptible people
to RVF infection. These results may be related to their
more vulnerability to the vector as well as to socioeco-
nomic/professional activities which allow a direct contact
with infected animals. Woods et al observed that children
< 15 years of age were less likely to have had RVFV infec-
tion [15]. One of the limitations of the study was that, IgG
was diagnostic tool for RVFV. IgG is the only indicator of
the person exposure to RVFV and may not be suitable
candidate test for detection recent infections. Capture
IGM is the suitable one. Because of fund constrains we
did not performed IGM as we did before in our previous
reports [2]. Actually this study was conducted to see if
RVFV was involved as cause of febrile illnesses in eastern
Sudan as well as other parts or not?. Thus strengthened
surveillance, early detection, management of cases
seemed to be among the best options to prevent exten-
sion of RVF epidemic foci. Precise estimation of specific
weight for each risk factor is a considerable guide to con-
struct an effective outbreak control plan.
Conclusion
There was high prevalence of seropostive to RVFV IgG in
this setting, more research is needed perhaps using other
methods like PCR and IGM.
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